Compare LIC MF Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
1.0
5.0
Min SIP Amount
₹200
₹100
Expense Ratio
2.36
1.87
NAV
₹31.33
₹42.02
Fund Started
08 Feb 2019
25 Jun 2018
Fund Size
₹78.30 Cr
₹6293.14 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
0.77%
6.10%
3 Year
20.05%
26.51%
5 Year
10.49%
15.90%
Equity
96.18%
97.62%
Cash
3.82%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.77% |
Torrent Pharmaceuticals Ltd. | 7.08% |
Apollo Hospitals Enterprise Ltd. | 6.84% |
Aurobindo Pharma Ltd. | 5.21% |
Divi's Laboratories Ltd. | 4.68% |
Fortis Healthcare Ltd. | 4.37% |
Onesource Specialty Pharma Ltd. | 4.17% |
Neuland Laboratories Ltd. | 3.97% |
Piramal Pharma Ltd. | 3.94% |
Ipca Laboratories Ltd. | 3.40% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
08 Feb 2019
25 Jun 2018
